QQQ0.69%

Trending

CMPS1.11%

home Symbol SLPnews

SLPSimulations Plus Inc.

$15.86

$0.05

(0.31%)

Pre-Market

Updated: 04:23 AM EDT·Prev Close $15.91

EarningsJul 15

Mkt Cap$320.86M

Vol1.00

Fundamentals

Mkt Cap

$320.86M

Volume

52W High

$28.44

52W Low

$11.09

PE Ratio

-5.09

Avg. Volume

366,653.91

EPS (Annual)

-$3.22

Rev/Employee

$371,732.39

Earnings

Jul 15

Neutral Sentiment

How do you feel about SLP?

Info

News

all

press releases

Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute

Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute Simulations Plus (SLP) Securities Investigation: Johnson Fistel Reviews Revenue Guidance Cut, $77.2M Impairment Charge, and Auditor Dispute PR Newswire SAN...

PR Newswire

More News

SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

PR Newswire

Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

Johnson Fistel, PLLP is investigating potential claims on behalf of Simulations Plus, Inc. (NASDAQ: SLP) investors concerning whether the Company or certain of its executive officers violated federal securities laws.The Simulations Plus investigation focuses on investor losses following the...

Business Wire

Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws and breached fiduciary duties to shareholders. Simulation Plus is a software company serving the pharmaceutical...

Business Wire

Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference

Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus or the Company), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn OConnor, Chief Executive Officer, will be participating in the 23rd Annual Craig-Hallum...

Business Wire

PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump

PTC jumped in pre-market trading after fiscal Q2 2026 revenue rose 22% and AI-driven product demand fueled stronger ARR growth and buybacks.

Zacks

Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push

Simulations Plus announces an Nvidia deal to accelerate AI drug modeling, but weak growth and momentum metrics raise concerns about the long-term outlook.read more...

Benzinga

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows

Business Wire

Do Options Traders Know Something About Simulations Plus Stock We Don't?

Investors need to pay close attention to SLP stock based on the movements in the options market lately.

Zacks

Cadence Q1 Earnings Top Estimates, 2026 Revenue Outlook Raised

CDNS tops Q1 estimates, launches agentic AI Super Agents, hits a record $8B backlog, and raises its 2026 revenue outlook.

Zacks

...

Advertisement|Remove ads.